Suchergebnisse - "O'Day, Steven J"

PubPharm (9)

1

A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma : results from the CAPRA study

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Silk, A. | O'Day, S. | Kaufman, H. | +19

2

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

enthalten in: Journal for ImmunoTherapy of Cancer | 2016

von Amin, A. | Lawson, D. | Salama, A. | +8

3

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

enthalten in: Journal for ImmunoTherapy of Cancer | 2016

von Amin, A. | Lawson, D. | Salama, A. | +8

4

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

enthalten in: Journal for immunotherapy of cancer | 2016

von Amin, A. | Lawson, D. | Salama, A. | +8

5

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

enthalten in: The lancet / Oncology | 2015

von Ribas, A. | Puzanov, I. | Dummer, R. | +33

6

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2011

von O’Day, S. | Pavlick, A. | Albertini, M. | +7

7

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2011

von O’Day, S. | Pavlick, A. | Albertini, M. | +7

8

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2011

von O’Day, S. | Pavlick, A. | Albertini, M. | +7

9

Biochemotherapy for Metastatic Melanoma with Limited Central Nervous System Involvement : Clinical Study

in: Oncology | 2003

von Boasberg, P. | O’Day, S. | Kristedja, T. | +7

1
[1]